DUBAI, United Arab Emirates, March 07, 2022 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the Glaucoma Treatment Market is forecasted to reach a net worth of US$ 7.6 Bn in 2032 from US$ 5.5 Bn in 2021 by registering a moderate CAGR of 3%. With the increasing proportion of the geriatric population in different geographic regions, glaucoma has emerged as a prevalent ailment.
Though there are some instances of successful glaucoma treatment in homeopathy, drugs and surgery are the prominent methods adopted by healthcare institutes. The requirement for various combinations of drugs has provided the necessary traction for the growth of the global glaucoma treatment market in recent years.
| Attributes | Details | |
| Glaucoma Treatment Market Size (2027) | US$ 11.05 Bn | |
| Glaucoma Treatment Market Size CAGR (2022-2032) | 3.2% | |
| Glaucoma Treatment Market Size Attraction | Growing infrastructure and demand for renewable energy to offer impetus. | |
Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-14351
During the Covid-19 pandemic years, the global glaucoma treatment market experienced a slowdown in market expansion and revenue generation, giving some way for a natural cure for glaucoma available in the locality. However, with the subsidence of Covid-19 cases, non-emergency medical services are pacing up with sufficient opportunities for growth of the glaucoma treatment market.
Higher demand for advanced surgical procedures supported by superior drug combinations for glaucoma remedies will propel the market growth for glaucoma treatment in the Asia Pacific, Latin America and the Middle East and Africa (MEA) countries during the forecast years.
“The growing concern for the maintenance of eye health has increased demand for glaucoma and eye pressure treatment services worldwide. This increase in demand is fuelling the further technological advancements for the best treatment for glaucoma, opening up new opportunities for glaucoma treatment market expansion.”—opines an FMI analyst.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14351
Scope of the Report
| Attributes | Glaucoma Treatment Market | Glaucoma Therapeutics Market | Glaucoma Surgery Devices Market | |||
| CAGR (2022 - 2032) | 3.2% | 6.7% | 25% | |||
| Market Value (2026) | US$ 11 Bn | US$ 10 Bn | US$ 60 Bn | |||
| Growth Factor | Innovation in new technologies to offer impetus to the market. | Rising research towards the development of prostaglandin analogs to boost adoption. | Rising awareness about the condition to offer growth prospects. | |||
| Opportunity | Investments in prostaglandin analogs to create opportunities. | Robust healthcare infrastructure in emerging countries to sustain demand. | Demand for minimally invasive surgeries to offer opportunities. | |||
| Key Trends | Ease of use of eye drops to remain a dominant market trend. | Development of effective therapeutics with ease of use to drive the market growth. | Intense focus on advanced technology for product development to remain a key trend. | |||
Key Takeaways
- The global glaucoma treatment market is poised to reach a value of US$ 6.86 Bn by 2028.
- POAG or primary open-angle Glaucoma Segment will be the dominant service providing holistic treatment for glaucoma, withholding a net worth of more than US$ 4.5 Bn alone in 2021.
- For drugs available for treatment for glaucoma and cataracts, the pharmacy segment will experience the highest growth rate than the other distribution channels by recording a CAGR of 3.3%.
- Among all the types of drug classes for glaucoma remedies, the prostaglandin analogs segment held a significant share of the global glaucoma treatment market by more than 30% in 2021.
- The growth prospects of North America in the glaucoma treatment market are more than the global average at nearly 3.4%.
- Europe will experience more moderate growth in the glaucoma treatment market with a CAGR of about 2.7% during the forecast period.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14351
Competitive Landscape
Major global glaucoma treatment market players include Cilla Inc., Akorn Operating Company LLC, Abb Vie, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Santen Pharmaceutical Co., Ltd.
Most of the major players are more focused on investing in research and testing for the development of new drug combinations for providing better options than natural remedies for glaucoma.
Analogs and eye drops for glaucoma are some of the major products for glaucoma drug manufacturers generating the highest revenue from the market. Following the strict regulations set by healthcare sectors in different parts of the world can hamper the pace of business expansion of most of the players operating in the glaucoma treatment market.
- Teva Pharmaceuticals strengthened its product portfolio by launching a generic version of AZOPT in March 2021. It was the first of its kind generic version of AZOPT (Brinzolamide Ophthalmic Suspension) 1% reducing the glaucoma treatment cost in the United States.
- Aerie Pharmaceuticals, Inc. and Santen Pharmaceutical Co., Ltd collaborated in December 2021 for commercializing their newly developed product Rhopressa/Rhokiinsa and Rocklatan/Roclanda in the Asia Pacific and Latin America countries. This business expansion of two major players will provide more glaucoma treatment options for the citizens of Latin America and Asia Pacific regions, particularly in China, India and Oceania.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Lung Cancer Therapeutics Market - The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Mn by 2026, exhibiting a CAGR of 13.4% in the forecast period.
Protein Crystallization and Crystallography Market - The global protein crystallization and crystallography market is estimated to reach US$ 2.23 billion in 2028.
Digital X-Ray Equipment Market - Digital X-Ray Equipment Market By Application (Orthopaedic, Cancer, Dental, Cardiovascular, and Other Applications), Technology (Computed Radiography and Direct Radiography), Portability (Fixed Systems and Portable Systems) & Region - Forecast 2022-2032.
Orthopedic Power Tools Market - Orthopedic Power Tools Market by Product Type (Large Bone Power Tools, Small Bone Power Tools, High-Speed Power Tools, Single Use (Disposable) Power Tools, Orthopedic Reamers, and Consumables), Technology (Pneumatic Powered, Battery Operated, and Electric Powered) & Region - Forecast 2022-2032.
Peri-implantitis Treatment Market - Peri implant disease is associated with two main entities - peri-implantitis and peri-implant mucositis. Peri-implant mucositis is an inflammatory reversible reaction in the soft tissues which surrounds the dental implant.
Neglected Tropical Disease Treatment Market - Neglected tropical disease treatment offers a great chance of survival for patients mainly belong to the poorest of the poor society, Neglected tropical disease treatment forms a group because all such conditions are strongly associated with poverty, impoverished environments, and majorly conditions mainly thrive in tropical regions.
Heparin-Induced Thrombocytopenia (HIT) Treatment Market - Heparin-Induced Thrombocytopenia (HIT) is an immune-mediated life-threatening complication. It is an adverse drug reaction caused by the generation of antibodies that activates platelet factor 4(PF-4) in the presence of heparin.
Staphylococcal Infection Treatment Market - Staphylococcus infection is caused by different types of Staphylococcus bacteria which is basically a gram-positive bacteria that can cause a wide range of infections in human body such as skin infection, food poisoning, toxic shock syndrome and other.
Leukemia Therapeutics Treatment Market - During the forecast period, the leukemia therapeutics treatment market is expected to record a CAGR of 7.1 per cent to reach a valuation of US$ 17 Bn by 2024, from a valuation of US$ 13 Bn in 2020.
Opioid-Induced Constipation (OIC) Treatment Market - Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the gastrointestinal tract's motility, making solid discharges and making patients strain.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/glaucoma-treatment-market
